Role of hepatic stellate cells in the pathogenesis of portal hypertension.
Marra
F
F
Dipartimento di Medicina Interna, Università degli Studi di Firenze, Firenze, Italy.
Pinzani
M
M
D000328:Adult; D000818:Animals; D001794:Blood Pressure / Q000502:physiology; D015220:Calcium Channels / Q000378:metabolism; D019332:Endothelin-1 / Q000502:physiology; D005355:Fibrosis; D018056:Hemorheology; D006801:Humans; D006975:Hypertension, Portal / Q000209:etiology* / Q000503:physiopathology; D015640:Ion Channel Gating; D008055:Lipids / Q000032:analysis; D008099:Liver / Q000294:innervation / Q000473:pathology*; D008103:Liver Cirrhosis / Q000150:complications / Q000503:physiopathology; D008106:Liver Cirrhosis, Experimental / Q000150:complications / Q000503:physiopathology; D009389:Neovascularization, Pathologic / Q000503:physiopathology; D009569:Nitric Oxide / Q000502:physiology; D020286:Pericytes / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D051381:Rats; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D015220:Calcium Channels; D019332:Endothelin-1; D008055:Lipids; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D009569:Nitric Oxide